Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Clara Martínez Vila"'
Publikováno v:
EJC Supplements, Vol 15, Iss , Pp 77-86 (2020)
Angiogenesis is a known hallmark in cancer and plays a crucial role in ovarian cancer carcinogenesis and invasion. Anti- angiogenic agents are active in ovarian cancer treatment either as monotherapy or combined with chemotherapy, immunotherapy or po
Externí odkaz:
https://doaj.org/article/3456d6610b5844a1a7c9cc3d89fd337a
Autor:
Alda Cardesin Revilla, Yolanda Escamilla Carpintero, Angels Martínez Arias, Clara Martínez Vila, Juan José Díaz Argüello, Rosa Rosell Ferrer, Mariana Campos Motamayor, Anton Aguilà Artal
Publikováno v:
Acta Otorrinolaringológica Española. 72:271-279
Resumen Introduccion y objetivos Dado el conocimiento epidemiologico del carcinoma escamoso de cabeza y cuello, pronostico y supervivencia segun el estadio al diagnostico, y ante la ausencia de programas de cribado que hayan demostrado ser coste-efec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43bc6bd6673183c6952c163eada83ab7
https://doi.org/10.1016/j.otorri.2020.06.006
https://doi.org/10.1016/j.otorri.2020.06.006
Autor:
Rosa Rosell Ferrer, Clara Martínez Vila, Alda Cardesin Revilla, Yolanda Escamilla Carpintero, Anton Aguilà Artal, Angels Martínez Arias, Juan José Díaz Argüello, Mariana Campos Motamayor
Publikováno v:
Acta Otorrinolaringologica (English Edition). 72:271-279
Introduction and objectives : Given the epidemiological knowledge of squamous cell carcinomas of the head and neck (SCHN), the prognosis in survival according to the staging at diagnosis and the absence of screening programmes that have proven cost-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53535e54422c62db5ff9987ce0bb0146
https://doi.org/10.1016/j.otoeng.2020.06.008
https://doi.org/10.1016/j.otoeng.2020.06.008
Autor:
Iván Victoria, Joan Padrosa, Elia Segui, Laia Fernandez, Lydia Gaba, Julia Giner Joaquim, Gustavo Ruiz, Clara Martínez-Vila, Francisco Aya Moreno, Juan C Laguna, Luis M Fernandez-Morales, Ana Maria Arance Fernandez
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 44(5)
Since the approval of immune checkpoint anti-programmed cell death protein 1 antibodies (pembrolizumab and nivolumab) and anti-cytotoxic T-lymphocyte-associated protein 4 (ipilimumab) in combination or monotherapy, significant advances have been made
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d564f037b9980125182304f411b24e
https://pubmed.ncbi.nlm.nih.gov/33950029
https://pubmed.ncbi.nlm.nih.gov/33950029